BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kytikova OY, Perelman JM, Novgorodtseva TP, Denisenko YK, Kolosov VP, Antonyuk MV, Gvozdenko TA. Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma. PPAR Res 2020;2020:8906968. [PMID: 32395125 DOI: 10.1155/2020/8906968] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Li H, Ma L, Li W, Zheng B, Wang J, Chen S, Wang Y, Ge F, Qin B, Zheng X, Deng Y, Zeng R. Proline metabolism reprogramming of trained macrophages induced by early respiratory infection combined with allergen sensitization contributes to development of allergic asthma in childhood of mice. Front Immunol 2022;13:977235. [DOI: 10.3389/fimmu.2022.977235] [Reference Citation Analysis]
2 Wang T, He C, Hu M, Wu H, Ou S, Li Y, Fan C. Subtyping children with asthma by clustering analysis of mRNA expression data. Front Genet 2022;13:974936. [DOI: 10.3389/fgene.2022.974936] [Reference Citation Analysis]
3 Sood A, Qualls C, Murata A, Kroth PJ, Mao J, Schade DS, Murata G. Potential for repurposing oral hypertension/diabetes drugs to decrease asthma risk in obesity. J Asthma 2022;:1-12. [PMID: 35796615 DOI: 10.1080/02770903.2022.2097919] [Reference Citation Analysis]
4 Research Accessibility Team (RAT). The microvascular hypothesis underlying neurologic manifestations of long COVID-19 and possible therapeutic strategies. Cardiovasc Endocrinol Metab 2021;10:193-203. [PMID: 34765889 DOI: 10.1097/XCE.0000000000000253] [Reference Citation Analysis]
5 Martinez J, Cook DN. What's the deal with efferocytosis and asthma? Trends Immunol 2021;42:904-19. [PMID: 34503911 DOI: 10.1016/j.it.2021.08.004] [Reference Citation Analysis]
6 Al Sharif M. Development of mode of action networks related to the potential role of PPARγ in respiratory diseases. Pharmacol Res 2021;172:105821. [PMID: 34403731 DOI: 10.1016/j.phrs.2021.105821] [Reference Citation Analysis]
7 Adhikari UK, Sakiz E, Zhou X, Habiba U, Kumar S, Mikhael M, Senesi M, Guang Li C, Guillemin GJ, Ooi L, David MA, Collins S, Karl T, Tayebi M. Cross-Linking Cellular Prion Protein Induces Neuronal Type 2-Like Hypersensitivity. Front Immunol 2021;12:639008. [PMID: 34394070 DOI: 10.3389/fimmu.2021.639008] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Kytikova OY, Novgorodtseva TP, Denisenko YK, Naumov DE, Gvozdenko TA, Perelman JM. Thermosensory Transient Receptor Potential Ion Channels and Asthma. Biomedicines 2021;9:816. [PMID: 34356881 DOI: 10.3390/biomedicines9070816] [Reference Citation Analysis]
9 Wu L, Yu Q, Cheng P, Guo C. PPARγ Plays an Important Role in Acute Hepatic Ischemia-Reperfusion Injury via AMPK/mTOR Pathway. PPAR Res 2021;2021:6626295. [PMID: 34285690 DOI: 10.1155/2021/6626295] [Reference Citation Analysis]
10 Li J, Guo C, Wu J. The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis. Drug Des Devel Ther 2021;15:2619-28. [PMID: 34168433 DOI: 10.2147/DDDT.S310163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Jabbari P, Sadeghalvad M, Rezaei N. An inflammatory triangle in Sarcoidosis: PPAR-γ, immune microenvironment, and inflammation. Expert Opin Biol Ther 2021;:1-9. [PMID: 33798017 DOI: 10.1080/14712598.2021.1913118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Pai AY, Wenziger C, Streja E, Argueta DA, DiPatrizio NV, Rhee CM, Vaziri ND, Kalantar-Zadeh K, Piomelli D, Moradi H. Impact of Circulating N-Acylethanolamine Levels with Clinical and Laboratory End Points in Hemodialysis Patients. Am J Nephrol 2021;52:59-68. [PMID: 33601382 DOI: 10.1159/000513381] [Reference Citation Analysis]
13 Zhang J, Cheng P, Dai W, Ji J, Wu L, Feng J, Wu J, Yu Q, Li J, Guo C. Fenofibrate Ameliorates Hepatic Ischemia/Reperfusion Injury in Mice: Involvements of Apoptosis, Autophagy, and PPAR-α Activation. PPAR Res 2021;2021:6658944. [PMID: 33603777 DOI: 10.1155/2021/6658944] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Ji J, Yu Q, Dai W, Wu L, Feng J, Zheng Y, Li Y, Guo C. Apigenin Alleviates Liver Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Autophagy via TGF-β1/Smad3 and p38/PPARα Pathways. PPAR Res 2021;2021:6651839. [PMID: 33574836 DOI: 10.1155/2021/6651839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Xia Y, Li J, Chen K, Feng J, Guo C. Bergenin Attenuates Hepatic Fibrosis by Regulating Autophagy Mediated by the PPAR-γ/TGF-β Pathway. PPAR Res 2020;2020:6694214. [PMID: 33488687 DOI: 10.1155/2020/6694214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
16 Rudko OI, Tretiakov AV, Naumova EA, Klimov EA. Role of PPARs in Progression of Anxiety: Literature Analysis and Signaling Pathways Reconstruction. PPAR Res 2020;2020:8859017. [PMID: 33312191 DOI: 10.1155/2020/8859017] [Reference Citation Analysis]
17 Logie E, Vanden Berghe W. Tackling Chronic Inflammation with Withanolide Phytochemicals-A Withaferin a Perspective. Antioxidants (Basel) 2020;9:E1107. [PMID: 33182809 DOI: 10.3390/antiox9111107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
18 Denisenko YK, Kytikova OY, Novgorodtseva TP, Antonyuk MV, Gvozdenko TA, Kantur TA. Lipid-Induced Mechanisms of Metabolic Syndrome. J Obes 2020;2020:5762395. [PMID: 32963827 DOI: 10.1155/2020/5762395] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]